Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 20/20 | 0.67 |
| ▸ | APP | P05067 | 2/20 | 0.67 |
| ▸ | CTSD | P07339 | 3/20 | 0.65 |
| ▸ | BACE2 | Q9Y5Z0 | 3/20 | 0.65 |
| ▸ | REN | P00797 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8143694 | 0.92 | BACE1 (0.77) | BACE1APPCTSDBACE2REN | |
| SCHEMBL4308372 | 0.92 | BACE1 (0.77) | BACE1APPCTSDBACE2REN | |
| SCHEMBL13953386 | 0.89 | BACE1 (0.62) | BACE1APPCTSDBACE2REN | |
| SCHEMBL13953510 | 0.89 | BACE1 (0.62) | BACE1APPCTSDBACE2REN | |
| SCHEMBL13953589 | 0.89 | BACE1 (0.62) | BACE1APPCTSDBACE2REN | |
| SCHEMBL4309940 | 0.88 | BACE1 (0.61) | BACE1APPCTSDBACE2REN | |
| SCHEMBL13932830 | 0.87 | BACE1 (0.86) | BACE1APPCTSDBACE2REN | |
| SCHEMBL8157422 | 0.87 | BACE1 (0.86) | BACE1APPCTSDBACE2REN | |
| SCHEMBL4306222 | 0.87 | BACE1 (0.86) | BACE1APPCTSDBACE2REN | |
| SCHEMBL13953471 | 0.87 | BACE1 (0.61) | BACE1APPCTSDBACE2REN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090042964-A1 | AMINO-5-[SUBSTITUTED-4-(DIFLUOROMETHOXY)PHENYL]-5-PHENYLIMIDAZOLONE COMPOUNDS AS BETA-SECRETASE INHIBITORS | WYETH (US) | 2009-02-12 | — | — | US | claimed |
| US-20090042964-A1 | AMINO-5-[SUBSTITUTED-4-(DIFLUOROMETHOXY)PHENYL]-5-PHENYLIMIDAZOLONE COMPOUNDS AS BETA-SECRETASE INHIBITORS | WYETH (US) | 2009-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042964-A1 | AMINO-5-[SUBSTITUTED-4-(DIFLUOROMETHOXY)PHENYL]-5-PHENYLIMIDAZOLONE COMPOUNDS AS BETA-SECRETASE INHIBITORS | BACE1, BACE2, APP | BACE1 1/4885APP 3/4885CTSD 88/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.